Preparation and assessment of chitosan-coated superparamagnetic Fe3O4 nanoparticles for controlled delivery of methotrexate.
In this study, Fe3O4 superparamagnetic nanoparticles were synthesized and stabilized by chitosan. Then the nanoparticles were characterized by Fourier transform infrared spectroscopy and transmission electron microscopy (TEM). Particle size distribution and Zeta potential of the particles also was assessed using Malvern Zetasizer. The paramagnetic behaviors of the uncoated and chitosan coated nanoparticles were measured using vibrating scanning magnetometry Particles morphology and size ranges of uncoated iron oxide nanoparticles were evaluated by TEM, showing uniform and narrow size distribution about 10 nm. After coating nanoparticles with chitosan and loading of methotrexate (MTX), the change in size was assessed using Zetasizer. Considerable increase in size was observed following the coating of the particles with chitosan and loading with MTX (the average size was 152 nm). Paramagnetic properties of the uncoated and chitosan-coated particles were assessed showing significant decrease in paramagnetic behavior after coating with chitosan, but it was enough to respond to the magnetic field. Finally loading efficiency, release rate and cytotoxicity of MTX were assessed indicating slow release behavior with the same levels of cell toxicity in SK-BR-3 cell lines, suggesting this formulation as a good candidate for the controlled delivery of MTX.
Pharmaceutical Sciences Research Centre, Faculty of Pharmacy, Shiraz University of Medical Sciences, Shiraz, I.R. Iran.
S
S
Mohammadi-Samani
Pharmaceutical Sciences Research Centre, Faculty of Pharmacy, Shiraz University of Medical Sciences, Shiraz, I.R. Iran ; Medicinal and Natural Products Chemistry Research Center, Shiraz University of Medical Sciences, Shiraz, I.R. Iran.
R
R
Miri
Pharmaceutical Sciences Research Centre, Faculty of Pharmacy, Shiraz University of Medical Sciences, Shiraz, I.R. Iran.
M
M
Salmanpour
Medicinal and Natural Products Chemistry Research Center, Shiraz University of Medical Sciences, Shiraz, I.R. Iran.
N
N
Khalighian
Pharmaceutical Sciences Research Centre, Faculty of Pharmacy, Shiraz University of Medical Sciences, Shiraz, I.R. Iran.
S
S
Sotoudeh
Institute for Cancer Research, School of Medicine, Shiraz University of Medical Sciences, Shiraz, I.R. Iran.
N
N
Erfani
Chitosan; Fe3O4; Magnetic targeting drug delivery; Methotrexate; Nanoparticles; Superparamagnetic